United States · Series F startup
Funding summaryUpdated 26 Oct 2026
$85Mraised across 6 rounds since 2006, from 6 sources
Each circle is a round, placed by date and sized by amount. The line above is the running total.
Domain Associates
Wellcome Trust
RBC Venture Partners
The Vertical GroupReported by pehub.com
The busiest backers across the latest rounds. A filled square is a round they joined; a dark one, a round they led.
Domain AssociatesNovo Holdings A/SWellcome TrustRBC Venture PartnersThe Vertical Group
Novo Holdings
Essex Woodlands Healthcare PartnersPOSCO BioVenturesFrom historical deal records. Wrong? Tell us.
Missing a round, or an investor who was in one? Tell us.
CellBiosciences's investors include Domain Associates, Novo Holdings A/S, Wellcome Trust, RBC Venture Partners and The Vertical Group, and 6 more on record.
CellBiosciences has raised $85M across 6 rounds since 2006.
CellBiosciences's most recent round was a Series F of $20M in Oct 2010.
CellBiosciences's largest round on record is $27M (Series B), in Jan 2006.
CellBiosciences's first round on record, in Jan 2006, was backed by Novo Holdings, Domain Associates and Wellcome Trust and 5 others.
CellBiosciences's latest named round is a Series F, in Oct 2010.
CellBiosciences is based in the United States.
In the same sector, and raised in the last eighteen months.
Search every investor by what they have actually funded, then narrow to your stage and market. Free.
United States · 
